Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Connell, CM
Raby, S
Beh, I
Flint, T
Description
Keywords
Cancer immunotherapy, T cell checkpoint inhibitor, clinical trial, glucocorticoid, immunomodulation, immunosuppression
Journal Title
Annals of Oncology
Conference Name
Journal ISSN
0923-7534
1569-8041
1569-8041
Volume Title
28
Publisher
Oxford University Press
Publisher DOI
Sponsorship
This work was supported by the Wellcome Trust Translational Medicine and Therapeutics Programme [RJAG/076 to TJ], Cancer Research UK and the Cambridge Translational Medicine and Therapeutics Academic Clinical Fellowship Programme (to CMC).